Since August 2021, Moderna’s stock has been in a downtrend.
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
交易结束：到达目标
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。